Vivoryon Therapeutics N.V.
VVY.AS · AMS
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -€20,568 | -€28,342 | -€28,156 | -€12,655 |
| Dep. & Amort. | €147 | €167 | €161 | €165 |
| Deferred Tax | €0 | €0 | -€199 | €3,117 |
| Stock-Based Comp. | €0 | €3,943 | €3,488 | €1,763 |
| Change in WC | -€1,064 | -€235 | €207 | -€579 |
| Other Non-Cash | €2,311 | €2,926 | €2,705 | -€3,068 |
| Operating Cash Flow | -€19,174 | -€21,541 | -€21,794 | -€11,257 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -€2 | -€14 | -€13 | -€28 |
| Net Acquisitions | €0 | €0 | €0 | €0 |
| Inv. Purchases | €0 | -€19,000 | €0 | €0 |
| Inv. Sales/Matur. | €10,000 | €9,000 | €0 | €0 |
| Other Inv. Act. | €0 | -€500 | €0 | €0 |
| Investing Cash Flow | €9,998 | -€10,514 | -€13 | -€28 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -€57 | -€94 | -€92 | -€90 |
| Stock Issued | €0 | €26,346 | €36,000 | €1,144 |
| Stock Repurch. | €0 | €0 | €0 | €0 |
| Dividends Paid | €0 | €0 | €0 | €0 |
| Other Fin. Act. | €0 | -€2,095 | -€2,527 | €0 |
| Financing Cash Flow | -€57 | €24,157 | €33,381 | -€827 |
| Forex Effect | €36 | -€95 | €320 | €467 |
| Net Chg. in Cash | -€9,197 | -€7,993 | €11,894 | -€11,645 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | €18,562 | €26,555 | €14,661 | €26,306 |
| End Cash | €9,365 | €18,562 | €26,555 | €14,661 |
| Free Cash Flow | -€19,176 | -€22,055 | -€21,807 | -€11,285 |